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Autoimmune thyroid diseases (AITD) are multifactorial endocrine diseases most frequently 
accompanied by Tg and TPO autoantibodies. Both antibodies have a higher prevalence in 
females and act under a strong genetic influence. 
 
To identify novel variants underlying thyroid antibody levels, we performed GWAS meta-
analysis on the plasma levels of TgAb and TPOAb in three Croatian cohorts, as well as 
gender specific GWAS and a bivariate analysis. 
 
No significant association was detected with the level of TgAb and TPOAb in the meta-
analysis of GWAS or bivariate results for all individuals. The bivariate analysis in females 
only revealed a genome-wide significant association for the locus near GRIN3A (rs4457391, 
P=7.76x10-9). The same locus had borderline association with TPOAb levels in females 
(rs1935377, P=8.58x10-8).  
 
In conclusion, we identified a novel gender specific locus associated with TgAb and TPOAb 
levels. Our findings provide a novel insight into genetic and gender differences associated 
with thyroid antibodies.  
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Thyroglobulin (Tg) and thyroid peroxidase (TPO) are major components of the thyroid gland, 
both engaged in the production of the thyroid hormones (1). Autoimmune thyroid diseases 
(AITD) are one of the most common autoimmune diseases, affecting 2-5% of the general 
population (2). The presence of circulating autoantibodies with specificity for Tg and TPO, 
might represent an early stage in the pathogenesis of AITD (3). Hashimoto thyroiditis (HT) 
and Graves' disease (GD) are autoimmune diseases in which the immune system turns against 
the thyroid gland. HT is characterised by destruction of thyroid gland and underproduction of 
thyroid hormones (hypothyroidism), whereas antibody stimulation of thyroid gland in GD 
results in overproduction of thyroid hormones (hyperthyroidism) (4, 5). The prevalence of 
TgAb and TPOAb positivity in the total and disease-free population is greater in females and 
increases with age, especially among females (6, 7). The prevalence of TgAb positivity is 60–
80% in patients with HT and 30–60% in patients with GD. Positivity of TPOAb is detected in 
90–95% patients with HT and 80% patients with GD (8).  
 
Many genetic loci seem to be associated with multiple traits in human complex diseases and 
have the direct biological influence on more than one phenotypic trait (9). HT and GD have 
some unique loci, as well as some common to both diseases, indicating that there is a shared 
genetic susceptibility to HT and GD (10). Since various autoimmune diseases often cluster 
within the same patient, identifying the basis for this shared pathogenesis could be important 
not only for the fundamental understanding of AITD mechanisms but also in the 
understanding of other associated diseases (11, 12). 
 
Thyroid antibodies are under the strong genetic influence. Autoimmune prevalence and 
clinical differences in thyroid function are known to be gender-related (6, 7, 13, 14). 
According to a twin study, the estimate of genetic influence on serum TgAb concentrations is 
39% in males and 75% in females (15). For serum TPOAb concentrations, the estimates are 
61% in males and 72% in females (15).  
 
Until now, two genome-wide associations studies were performed on TPO antibody in general 
population, one in Caucasians (16), and the other in an Asian (Korean) population (17). Also, 
there is one meta-analysis (18) in which previous GWAS findings (16) were used as a basis 
for an identification of additional novel genetic variants. Those studies have reported the 
genome-wide association of several loci with TPOAb level and/or positivity, including 
variants near TPO, HCP5, HLA-DPB1 and in ATXN2, MAGI3, KALRN, BACH2, RERE, HLA-
DOB genes (16-18). Although the heritability of TPOAb accounts for around 70% (15), the 
identified risk loci for AITD accounts for only 4% of the heritability. The genetic association 
of TgAb has not been analysed on a genome-wide scale so far. 
 
The aim of this study was to identify novel loci associated with thyroid antibodies. We 
performed genome-wide meta-analysis for TgAb plasma levels in 2629 individuals from three 
Croatian cohorts for the first time. Genome-wide meta-analysis for TPOAb plasma levels was 


















The study was carried out on samples from three Croatian populations: the mainland city of 
Split and the islands of Vis and Korcula. The samples were obtained from the large-scale 
project of “10,001 Dalmatians” (19). Cohorts’ description is reported in Table 1. We excluded 
participants with known thyroid pathologies, the ones that underwent thyroid surgery or were 
treated for thyroid conditions. After these exclusions, 2629 individuals were included in the 
analyses for TgAb level, and 2618 for TPOAB level. The study was approved by the Research 
Ethics Committees in Croatia and Scotland, and all participants provided informed consent. 
 
Genotyping and Imputation  
Genotyping platforms and quality control procedures are summarized in Table 2. SHAPEIT2 
was used for genotypes pre-phasing, along with duoHMM for refine phasing (20, 21). 
Samples from Split cohort were collected and genotyped in two rounds (Split1 and Split2) 
with two different genotyping platforms (Table 2). Cohorts of Vis, Korcula, and Split2 were 
directly imputed using 1000 Genomes project phase I version 3, whereas for the imputation of 
Split1 a merged reference panel of 1000 Genomes and Split2 was used. For imputation of 
Split cohorts, we used SNPTEST, while for Vis and Korcula cohorts IMPUTE2 (22, 23). 
Variants with minor allele frequency >5%, no significant deviation from HWE (p >10-7), and 
imputation info score > 0.4 were kept for further analysis. The final number of overlapping 
SNPs was 5 527 232. 
 
Measurement of Tg and TPO antibodies 
Plasma TgAb and TPOAb were determined by a sandwich chemiluminescence immunoassay 
method in the Laboratory of Biochemistry, Department of Nuclear Medicine, University 
Hospital Split. The immunoassay was conducted in a fully automated instrument "Liaison" 
Biomedica Chemiluminescence Analyzer, using LIAISON®Anti-Tg and LIAISON®Anti-TPO 
in vitro assays for the quantitative determination of TgAb and TPOAb in the plasma. The 
reference range of TgAb is 5-100 IU/mL, and for the TPOAb is 1-16 IU/mL. 
 
Statistical analyses 
Genome-wide association analyses 
TgAb and TPOAb levels were adjusted for age and sex under a linear regression model. 
Derived residuals were inverse-normal transformed and included in the linear mixed model, 
which accounts for population structure and relatedness. Association analysis was performed 
assuming an additive genetic model to test for association between each SNP and adjusted 
TgAb and TPOAb levels.  For the Split sample analysis was carried out using a combination 
of R-package GenABEL and SNPTEST software, while for the Korčula and Vis samples 
association analyses were conducted using R-packages GenABEL and VariABEL (24-26). 














analysis. There was no need for adjustments (λTgAb_Korčula=1.00, λTgAb_Split=0.93, 
λTgAb_Vis=1.01; λTPOAb_Korčula=0.99, λTPOAb_Split= 1.00, λTPOAb_Vis=1.02). 
Meta-analyses 
We combined evidence of associations from single GWAS using inverse-variance fixed-effect 
meta-analysis. Meta-analyses showed no significant evidence for inflated statistics 
(λTgAb=0.97, λTPOAb=1.01) hence no genomic correction was applied. Manhattan and quantile-
quantile (QQ) plots were generated using the qqman R package (27). Regional association 
plots for loci of interest (400 kb) were created using Locus Zoom based on 1000 genomes 
EUR population (28). Illumina GenomeStudio software package was used to create cluster 
plots for confirmation of genotyping quality for associated SNPs. In cases where the SNP of 
interest was imputed, and not directly genotyped, cluster plots were created for directly 
genotyped SNPs that were in high LD with the SNP of interest (r2 > 0.8). The genome-wide 
significance of association was defined as 𝑝 − 𝑣𝑎𝑙𝑢𝑒 ≤ 5 × 10−8. Meta-analyses were 
performed with the R-package MetABEL (29).  
Gender specific analyses 
The prevalence of positive TPOAb and positive TgAb in the general population is higher in 
females than males (6). To identify gender specific effects we performed GWAS for each 
gender separately in each cohort. We used the same procedures as in the primary analyses 
except for the gender covariate. Association results were meta-analysed using the inverse-
variance fixed-effects method. The total sample sizes for TgAb were 1596 for women and 
1033 for men, while 1593 for women and 1025 for men for the TPOAb. 
 
Bivariate analysis 
We applied a multiple-trait analysis method to test the association between each SNP and the 
two correlated traits TgAb and TPOAb simultaneously, since joint analysis of correlated traits 
may increase power for identification of novel loci (30). The association was tested using 
multivariate analysis of variance (MANOVA). Multi-trait association test statistic was 
calculated on the basis of the summary statistics from single univariate GWAS. We have also 
performed bivariate analysis of TgAb and TPOAb for females. Correlation amongst 
antibodies in males was not sufficient for the performance of bivariate analysis. 
 
Pathway analysis 
Pathway analysis was performed with ConsensusPathDB (http://cpdb.molgen.mpg.de) (31, 
32). For each of the loci with 𝑃 < 5𝑥10−6, downstream genes in ± 500 kb window were 
extracted and used as the input for analysis. The significance of results was defined as a 𝑃 <
















Suggestive associations from genome-wide meta-analyses of TgAb and TPOAb levels are 
shown in Supplementary Table 1 and 2. We did not find any significant association in the 
meta-analysis for TgAb or TPOAb level. The Manhattan and Quantile-quantile plots for both 
traits are shown in Supplementary Figure 1 and 2.  
Genome-wide meta-analysis of TgAb levels in females revealed a borderline significant 
association with rs4710782 genetic variant. SNP is located near protein coding gene DLL1 
(Table 3, Figure 1 and 2).  
 
The rs1935377 locus had borderline significance in females for association with TPOAb 
(reference allele C, P=8.58x10-8) (Table 3, Figure 1 and 2). The SNP is located near protein 
coding gene GRIN3A. 
 
Top findings from bivariate genome-wide meta-analyses are shown in Supplementary Figure 
3 and Supplementary Table 3. The bivariate analysis in females revealed a genome-wide 
significant rs4457391 locus near GRIN3A gene (reference allele G, P= 7.76x10-9) (Table 3, 
Figure 1 and 2).  
 
Pathway analysis 
No enrichment was obtained in general population for neither TgAb nor TPOAb. Results of 
pathway analyses performed for each gender separately are shown in the Supplementary 
Table 4 and 5.  
For females, there were ten significantly enriched pathways at the 𝑃 < 0.01 for TgAb level, 
while only one pathway was enriched for the level of TPOAb. For males, the enrichment for 
TgAb level was obtained for twenty-nine significant pathways at the 𝑃 < 0.01, while two 
pathways were enriched for the level of TPOAb (Supplementary Table 4 and 5).  
 
Replication of previous GWA findings 
We investigated variants that were previously associated with the level or/and positivity of 
TPOAb (16, 18). Nine loci were reported in previous studies (TPO, ATXN2, MAGI3, KALRN, 
BACH2, RERE, HCP5, HLA-DOB, HLA-DPB1), however locus HLA-DOB could not be 
tested since the SNPs or any surrogate (r2>0.5) were not available in our data. From eight 
reported variants that were available for the analysis in our data set, two were nominally 
replicated with P< 0.05, SNP rs11675434 for TPO gene (P=0.009) and SNP rs653178 in 
ATXN2 gene (P=0.035). All other variants with available data for effect sizes were similar in 

















Our study confirms the gender specificity of genetic influences on serum thyroid antibody 
level. In females, a novel significantly associated locus near GRIN3A gene was identified in 
the bivariate analysis of TgAb and TPOAb, and the same locus showed borderline 
significance in association with TPOAb levels. Furthermore, we detected marginally 
significant locus associated with variation in TgAb levels in females (DLL1). Genetic variants 
affecting the TgAb level at a genome-wide scale are analysed for the first time in this study.     
 
The levels of TPOAb and TgAb are correlated and participate in the onset and diagnosis of 
AITD (33). In our study, an intermediate correlation between both antibodies was found in 
our 3 general populations (r=0.5-0.7) as well as in females only (r=0.6-0.7), which enabled us 
to perform the bivariate analysis. The bivariate analysis revealed a significant association for 
a locus near the GRIN3A gene in females, with rs4457391 as a leading SNP (P=7.76x10-9). 
The rs4457391 SNP showed evidence of association for the level of TPOAb and TgAb in 
females (P=1.04x10-7 and P=1.17x10-5, respectively). The same locus with rs1935377 as 
leading SNP was marginally associated with TPOAb levels (P=8.58x10-8) and suggestively 
associated at the bivariate analysis (P=3.09x10-7). The rs1935377 is in moderate LD with 
rs4457391 (r2=0.72, 1000Genomes phase3). Both these polymorphisms showed no 
association in men with p values < 0.05, however effect sizes were in the same direction as in 
females.  
GRIN3A gene encodes a subunit of the N-methyl-D-aspartate (NMDA) receptors, which 
belongs to the superfamily of glutamate-regulated ion channels. GRIN3A gene is expressed in 
several tissues, mostly in brain, bone marrow, immune system, female and male tissue (34). 
The GRIN3A gene is associated with the high-density lipoprotein (HDL) cholesterol levels 
and suggestively associated with the low-density lipoprotein (LDL) cholesterol and 
triglyceride levels (35). Decreased levels of thyroid hormones in the liver have an effect on 
the breakdown of circulating cholesterol, consequently, the higher level of triglycerides, total 
and LDL cholesterol and lower level of HDL cholesterol are associated with hypothyroidism 
(36). It is important to emphasize that Eriksson et al. found evidence of association of intronic 
variant (rs9792648, 2.7x10-5) in GRIN3A gene with the hypothyroidism (37). A recent study 
by Joehanes et al. showed that SNPs associated with GRIN3A have the trans-eQTL effect, 
thus may act on phenotypes by affecting the expression of distant genes (38). For distant 
affected genes (ZNF782, LCE2B, TEKT5 and MORF4L2) from the study (38), 
polymorphisms with evidence of association with the level of hypothyroidism, LDL, HDL 
and total cholesterol, as well as with adiponectin level were found (37, 39-42). For 
polymorphisms in ZNF782 gene evidence of genome-wide association with hypothyroidism 
(P=10-5), as well as with LDL and total cholesterol level (P=10-2-10-3) were detected.  
 
Genes underlying AITD can be divided into thyroid-specific genes and immunoregulatory 
genes (14). GD and HT, although clinically antithetical, share number of immunological 
features including thyroid lymphocytic infiltration and autoreactivity against the key thyroid 
autoantigens (43). Different genes and mechanisms seem to be implicated in autoimmune 















Gender specific GWAS meta-analysis identified a novel locus associated with TgAb levels in 
females. Identified variant rs4710782 (P=6x10-8) is located on chromosome 6, 9 kb upstream 
of the protein coding gene DLL1. DLL1 is a human homolog of the Notch Delta ligand and a 
member of the delta/serrate/jagged family (44). It plays a role in mediating cell fate decisions 
during lymphopoiesis. Notch ligand Delta-1 inhibits the differentiation of human 
hematopoietic progenitors into the B cell lineage, while promotes the emergence of cells with 
a phenotype of T cell/natural killer (NK) precursor (45). Notch1 signalling plays a role in 
promoting maturation into both the CD4 and CD8 T cell lineages (46). CD4 T cells induce B 
cells in antibody production both in HD and GD, while CD8 T cells cause the death of 
thyrocytes in HT (8). Variations near DLL1 gene are associated with type 1 diabetes (T1D) 
(47) and suggestively associated with systemic lupus erythematosus (SLE) (48). T1D, as well 
as SLE, frequently occur with AITD within the same individuals (49, 50). 
 
In general population, bivariate analysis revealed some interesting, suggestive associations 
with PDE10A gene (rs611909, P=2.37x10-6), which was previously associated with thyroid 
stimulating hormone (TSH) levels, as well as with the hypothyroidism (43). Likewise, NFIA 
gene (rs17121639, P=2.97x10-6), previously associated with the level of TSH (43), had the 
suggestive association in the general population. These findings imply on the possibility of 
shared genetic susceptibility for thyroid function and autoimmunity. 
 
While there were no functionally enrichment pathways for general populations, interesting 
findings were obtained for both antibodies in gender specific manner. Most of the 
enrichments were related with different immune and inflammatory responses. The most 
interesting pathways enriched for TgAb levels in females were Proteasome Degradation 
(Wikipathways), Notch, Hedgehog and GPCR signaling-G alpha i (INOH). For TPOAb levels 
in females, the pathway for Neutrophil degranulation (Reactome) was enriched. The most 
interesting pathway enriched for TgAb levels in males were Alpha9 beta1 integrin signaling 
events (PID) and Vitamin D Receptor Pathway (Wikipathways), while for the TPOAb 
Inflammatory mediator regulation of TRP channels (KEGG) and Vitamin D Receptor 
Pathway (Wikipathways).  
 
Our study has helped in additional clarification of genetic variants associated with the TgAb 
and the TPOAb level. Thyroid autoimmunity is a consequence of the complex interaction of 
multiple genes and pathways, and possibly has different ethology depending on the gender. 
More GWA studies will be needed in the further enlightenment of this complex trait. 
 
There are several limitations in our study. We had a modest number of participants for 
genome-wide association analyses, a larger study should be performed in order to replicate 
our findings and discover novel associated loci. Also, our analysis was restricted to 
participants of European ancestry, thus further GWAS on populations of different ancestry 
will be required. We did not perform additional functional studies for identified variants to 

















We identified gender specific genetic factors associated with thyroid autoimmunity. We 
detected significantly associated locus (GRIN3A) in females with bivariate analysis, and 
likewise, the same locus was marginally associated in females with variation in TPOAb 
levels. Furthermore, we found a novel locus (DLL1) marginally associated with TgAb levels 
in females. Overall, our findings add to the knowledge of shared genetic susceptibility 
affecting thyroid antibodies, as well as of genetic factors that differently affect thyroid 
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Tables and figures  
 
Table 1. Characteristics of study participants. 
Variables for Tg-Ab Split Korčula Vis 
Overall sample size 942 819 868 
Women, n (%) 587 (62%) 522 (64%) 487 (56%) 
Median age, (qL,qU) 52 (40,61) 57 (47,67) 57 (45,69) 
Median Tg-Ab, IU/mL (qL,qU) 6.90 (5.00,15.80) 11.90 (8.10, 32.25) 9.90 (5.10,19.20) 
Variables for TPO-Ab Split Korčula Vis 
Overall sample size 942 819 857 
Women, n (%) 587 (62%) 522 (64%) 484 (57%) 
Median age, (qL,qU) 52 (40,61) 57 (47,67) 57 (45,69) 
Median TPO-Ab, IU/mL (qL,qU) 2.5 (1.3, 7.9) 7.90 (3.85, 18.10) 4.10 (1.80, 11.50) 















Table 2. Genotyping methods and quality control procedures. 














































Call rate ≥98% per SNP ≥98% per SNP ≥98% per SNP ≥98% per SNP 
MAF ≥1% ≥1% ≥1% ≥1% 




Call rate ≥97% ≥97% >97% >95% 
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SNP - single nucleotide polymorphism 
Chr.- chromosome 
MAF - minor allele frequency 
β - effect size 

















Figure 1. A) Manhattan plot of SNPs for the bivariate and meta-analysis of females in three cohorts. 
The 𝑦-axis shows the −log10 P values of 5 527 232 SNPs, and the x-axis shows their chromosomal 
positions. The red line indicates the threshold for significant hits (P=5x10-8) while the blue line 
indicates the threshold for suggestive hits (P=5x10-6). Gene labels are provided for suggestive hits 
(P=5x10-6) only B) Manhattan plot of SNPs for TgAb levels in the meta-analysis of females in three 















Figure 2. A) Regional association plot for bivariate and meta-analysis of females in three cohorts for 
the locus rs4457391 on chromosome 9. SNPs are plotted by position against association with two 
correlated traits TgAb and TPOAb simultaneously (−log10 P values). The purple diamond highlights 
the most significant SNP in the meta-analysis, whereas the colours of other variant represent LD with 
most significant SNP. B) Regional association plot for TgAb level in the meta-analysis of females in 
three cohorts for the locus rs4710782 on chromosome 6. SNPs are plotted by position against 
association with TgAb (−log10 P values). C) Regional association plot for TPOAb level in the meta-
analysis of females in three cohorts for the locus rs1935377 on chromosome 9. SNPs are plotted by 
















Supplementary Table 1. Associations of suggestively associated single nucleotide 
polymorphisms (P=5x10-6) with TgAb level. 
 
Supplementary Table 2. Associations of suggestively associated single nucleotide 
polymorphisms (P=5x10-6) with TPOAb level. 
 
Supplementary Table 3. Associations of suggestively associated single nucleotide 
polymorphisms (P=5x10-6) with both correlated traits. 
 
Supplementary Table 4. Enrichment results obtained from ConsensusPathDB for TgAb. 
 
Supplementary Table 5. Enrichment results obtained from ConsensusPathDB for TPOAb. 
 
Supplementary Table 6. Association values of the significant results of the previously 
published study in our data-set for the level of TPOAb. 
 
 
Supplementary Figure 1. The Manhattan and Quantile-quantile plots for the level of TgAb. 
 
Supplementary Figure 2. The Manhattan and Quantile-quantile plots for the level of TPOAb. 
 

















 GRIN3A locus was associated with thyroid antibodies levels in females 
 GRIN3A locus was marginally associated with TPOAb levels in females 
 DLL1 locus was marginally associated with TgAb levels in females 
 Gender specificity of genetic influences on thyroid antibody level was confirmed 
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